Good Day BIO: Nkarta's 'natural killers' are killing blood cancer

April 26, 2022
It’s been a good week for biotech trials. Nkarta Therapeutics, led by BIO’s Chair, announced positive data in two trials of its natural killer cell therapies targeting advanced blood cancer, and gene edited mosquitoes “behaved as planned” in the first trial in the…
Biotechnology Innovation Organization (BIO)
 
 
 
Ted Love -  play button.png
 
 
BIO Beltway Report
Facebook
Twitter
LinkedIn
YouTube